Paper41003014
Metabolomic Profiling Reveals Distinct Signatures in Primary and Secondary Polycythemia.
Yıldırım M and 9 others. Metabolites, 2025. Cited by 3 papers, by iCite.
Cite this record
ConductScience Library. Metabolomic Profiling Reveals Distinct Signatures in Primary and Secondary Polycythemia. Papers, record 41003014. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41003014
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References79
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 26771115 | The Emerging Hallmarks of Cancer Metabolism. | Cell Metab | 2016 | https://conductscience.org/library/papers/26771115 | PubMed |
| 2 | 31954874 | Kynurenine pathway, NAD+ synthesis, and mitochondrial function: Targeting tryptophan metabolism to promote longevity and healthspan. | Exp Gerontol | 2020 | https://conductscience.org/library/papers/31954874 | PubMed |
| 3 | 23558526 | A role for reactive oxygen species in JAK2 V617F myeloproliferative neoplasm progression. | Leukemia | 2013 | https://conductscience.org/library/papers/23558526 | PubMed |
| 4 | 33553149 | Thyroid Hormones Interaction With Immune Response, Inflammation and Non-thyroidal Illness Syndrome. | Front Cell Dev Biol | 2020 | https://conductscience.org/library/papers/33553149 | PubMed |
| 5 | 37173188 | Emerging roles of nucleotide metabolism in cancer. | Trends Cancer | 2023 | https://conductscience.org/library/papers/37173188 | PubMed |
| 6 | 39379377 | Metabolic regulation of the immune system in health and diseases: mechanisms and interventions. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39379377 | PubMed |
| 7 | 35453641 | The Selenoprotein Glutathione Peroxidase 4: From Molecular Mechanisms to Novel Therapeutic Opportunities. | Biomedicines | 2022 | https://conductscience.org/library/papers/35453641 | PubMed |
| 8 | 33028824 | NAD+ metabolism: pathophysiologic mechanisms and therapeutic potential. | Signal Transduct Target Ther | 2020 | https://conductscience.org/library/papers/33028824 | PubMed |
| 9 | 31751479 | Sugar thieves and addicts: nutrient subversion in JAK2 MPNs. | Blood | 2019 | https://conductscience.org/library/papers/31751479 | PubMed |
| 10 | 29290465 | Selenium Utilization by GPX4 Is Required to Prevent Hydroperoxide-Induced Ferroptosis. | Cell | 2018 | https://conductscience.org/library/papers/29290465 | PubMed |
| 11 | 17574023 | A microenvironment-induced myeloproliferative syndrome caused by retinoic acid receptor gamma deficiency. | Cell | 2007 | https://conductscience.org/library/papers/17574023 | PubMed |
| 12 | 20655352 | Oxidative stress is increased in primary and post-polycythemia vera myelofibrosis. | Exp Hematol | 2010 | https://conductscience.org/library/papers/20655352 | PubMed |
| 13 | 31890207 | Fat for fuel: lipid metabolism in haematopoiesis. | Clin Transl Immunology | 2019 | https://conductscience.org/library/papers/31890207 | PubMed |
| 14 | 40413366 | Influence of homocysteine on regulating immunothrombosis: mechanisms and therapeutic potential in management of infections. | Inflamm Res | 2025 | https://conductscience.org/library/papers/40413366 | PubMed |
| 15 | 33634867 | Polycythaemia vera: molecular genetics, diagnostics and therapeutics. | Vox Sang | 2021 | https://conductscience.org/library/papers/33634867 | PubMed |
| 16 | 28479188 | Vitamin A-Retinoic Acid Signaling Regulates Hematopoietic Stem Cell Dormancy. | Cell | 2017 | https://conductscience.org/library/papers/28479188 | PubMed |
| 17 | 26979502 | Metabolomics: beyond biomarkers and towards mechanisms. | Nat Rev Mol Cell Biol | 2016 | https://conductscience.org/library/papers/26979502 | PubMed |
| 18 | 36230834 | Metabolic Biomarkers Affecting Cell Proliferation and Prognosis in Polycythemia Vera. | Cancers (Basel) | 2022 | https://conductscience.org/library/papers/36230834 | PubMed |
| 19 | 39169031 | The JAK-STAT pathway: from structural biology to cytokine engineering. | Signal Transduct Target Ther | 2024 | https://conductscience.org/library/papers/39169031 | PubMed |
| 20 | 35785147 | Metabolic Regulation of Hematopoietic Stem Cells. | Hemasphere | 2022 | https://conductscience.org/library/papers/35785147 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 3 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42397475 | LC-QQQ serum metabolomics reveals disease-specific metabolic signatures and diagnostic metabolite panels distinguishing polycythaemia vera from secondary polycythaemia. | Metabolomics | 2026 | https://conductscience.org/library/papers/42397475 | PubMed |
| 42291732 | Sphingolipid metabolism and hematologic disorders: current understanding and future directions. | Front Physiol | 2026 | https://conductscience.org/library/papers/42291732 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| TRH | 7200 | PubTator's text mining | https://conductscience.org/library/genes/7200 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41003014
GET https://conductscience.org/api/papers/v1/41003014/references?page=2